Compounds and methods for kinase modulation, and indications therefor
US-2016168146-A1 · Jun 16, 2016 · US
Compounds and methods for kinase modulation, and indications therefor
US9624213B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9624213-B2 |
| Application number | US-201213820734-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 1, 2012 |
| Priority date | Feb 7, 2011 |
| Publication date | Apr 18, 2017 |
| Grant date | Apr 18, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of formula: or a pharmaceutically acceptable salt, a hydrate, a solvate, a tautomer, or a stereoisomer thereof. 2. A compound which is: 3. A pharmaceutical composition comprising the compound of claim 1 or a pharmaceutically acceptable salt, a hydrate, a solvate, a tautomer, or a stereoisomer thereof, and a pharmaceutically acceptable excipient or carrier. 4. A pharmaceutical composition comprising the compound of claim 2 and a pharmaceutically acceptable excipient or carrier.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Immunosuppressants, e.g. drugs for graft rejection · CPC title
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
Immunomodulators · CPC title
Antineoplastic agents · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9624213B2 cover?
- Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
- Who is the assignee on this patent?
- Ibrahim Prabha, Zhang Chao, Spevak Wayne, and 9 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/506. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).